Anthony Petrone
Stock Analyst at Mizuho
(3.87)
# 699
Out of 4,712 analysts
160
Total ratings
48.25%
Success rate
9.82%
Average return
Main Sectors:
Stocks Rated by Anthony Petrone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HOLX Hologic | Maintains: Outperform | $90 → $87 | $72.60 | +19.83% | 8 | Nov 5, 2024 | |
| TFX Teleflex | Maintains: Neutral | $275 → $250 | $179.51 | +39.27% | 7 | Nov 1, 2024 | |
| LIVN LivaNova | Maintains: Outperform | $80 → $70 | $46.56 | +50.34% | 7 | Oct 31, 2024 | |
| BSX Boston Scientific | Maintains: Outperform | $100 → $110 | $90.66 | +21.33% | 8 | Oct 24, 2024 | |
| ABT Abbott Laboratories | Maintains: Neutral | $115 → $130 | $114.99 | +13.05% | 4 | Oct 17, 2024 | |
| ADMA ADMA Biologics | Maintains: Buy | $12 → $14 | $17.45 | -19.77% | 6 | Jun 20, 2024 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $65 → $70 | $45.94 | +52.37% | 6 | Jun 6, 2024 | |
| ALC Alcon | Maintains: Buy | $100 → $105 | $85.65 | +22.59% | 8 | May 15, 2024 | |
| STAA STAAR Surgical Company | Maintains: Buy | $53 → $55 | $24.21 | +127.18% | 7 | May 8, 2024 | |
| LNTH Lantheus Holdings | Maintains: Buy | $90 → $100 | $92.07 | +8.61% | 5 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $105 | $79.51 | +32.06% | 6 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $16 | $3.72 | +330.11% | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $100 | $151.16 | -33.84% | 6 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $105 | $75.65 | +38.80% | 7 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $215 | $233.18 | -7.80% | 15 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 | $188.48 | +32.64% | 6 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $44 | $55.00 | -20.00% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $9.42 | +48.62% | 4 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $103 → $115 | $92.34 | +24.54% | 14 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $98 | $80.74 | +21.38% | 4 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $350 → $390 | $534.88 | -27.09% | 6 | Jan 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $63 → $67 | $92.84 | -27.83% | 2 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $115 | $77.57 | +48.25% | 14 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $200 → $175 | $106.87 | +63.75% | 3 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $30 → $25 | $14.82 | +68.69% | 3 | May 13, 2020 |
Hologic
Nov 5, 2024
Maintains: Outperform
Price Target: $90 → $87
Current: $72.60
Upside: +19.83%
Teleflex
Nov 1, 2024
Maintains: Neutral
Price Target: $275 → $250
Current: $179.51
Upside: +39.27%
LivaNova
Oct 31, 2024
Maintains: Outperform
Price Target: $80 → $70
Current: $46.56
Upside: +50.34%
Boston Scientific
Oct 24, 2024
Maintains: Outperform
Price Target: $100 → $110
Current: $90.66
Upside: +21.33%
Abbott Laboratories
Oct 17, 2024
Maintains: Neutral
Price Target: $115 → $130
Current: $114.99
Upside: +13.05%
ADMA Biologics
Jun 20, 2024
Maintains: Buy
Price Target: $12 → $14
Current: $17.45
Upside: -19.77%
Establishment Labs Holdings
Jun 6, 2024
Maintains: Buy
Price Target: $65 → $70
Current: $45.94
Upside: +52.37%
Alcon
May 15, 2024
Maintains: Buy
Price Target: $100 → $105
Current: $85.65
Upside: +22.59%
STAAR Surgical Company
May 8, 2024
Maintains: Buy
Price Target: $53 → $55
Current: $24.21
Upside: +127.18%
Lantheus Holdings
May 3, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $92.07
Upside: +8.61%
May 1, 2024
Maintains: Buy
Price Target: $110 → $105
Current: $79.51
Upside: +32.06%
Apr 11, 2024
Maintains: Neutral
Price Target: $20 → $16
Current: $3.72
Upside: +330.11%
Apr 11, 2024
Maintains: Neutral
Price Target: $85 → $100
Current: $151.16
Upside: -33.84%
Apr 11, 2024
Maintains: Buy
Price Target: $95 → $105
Current: $75.65
Upside: +38.80%
Mar 27, 2024
Maintains: Buy
Price Target: $215
Current: $233.18
Upside: -7.80%
Mar 27, 2024
Maintains: Buy
Price Target: $250
Current: $188.48
Upside: +32.64%
Mar 6, 2024
Maintains: Buy
Price Target: $30 → $44
Current: $55.00
Upside: -20.00%
Mar 1, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $9.42
Upside: +48.62%
Mar 1, 2024
Maintains: Buy
Price Target: $103 → $115
Current: $92.34
Upside: +24.54%
Feb 21, 2024
Maintains: Buy
Price Target: $95 → $98
Current: $80.74
Upside: +21.38%
Jan 25, 2024
Maintains: Neutral
Price Target: $350 → $390
Current: $534.88
Upside: -27.09%
Aug 3, 2023
Downgrades: Hold
Price Target: $63 → $67
Current: $92.84
Upside: -27.83%
Feb 8, 2023
Maintains: Buy
Price Target: $110 → $115
Current: $77.57
Upside: +48.25%
Nov 5, 2021
Maintains: Buy
Price Target: $200 → $175
Current: $106.87
Upside: +63.75%
May 13, 2020
Maintains: Hold
Price Target: $30 → $25
Current: $14.82
Upside: +68.69%